 Evaluation rotavirus vaccine correlates protection healthy infants safety immunogenicity efficacy rotavirus vaccine double-blind placebo-controlled trial healthy infants months age dose vaccine placebo Vaccination safe antibody response antibody vaccinees antibody human rotavirus serotypes vaccination number symptomatic episodes rotavirus diarrhea number moderate rotavirus illnesses different vaccine placebo recipients serotype rotavirus season slight significant decrease mean symptom score vaccine recipients overall lack efficacy protection previous rotavirus infection high levels antibody maternal serotype antibody titer equal